Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

NCT01566526 · clinicaltrials.gov ↗

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Oedema

Interventions

DRUG: dexamethasone intravitreal implant 0.7 mg

Sponsor

Allergan